Interestingly, transcript levels of VEGFA varied among tumor samples and differential expression of VEGFA was not statistically significant in OSA tumors compared to osteoblast cells; however, this may have been due, in part, to variations in stroma/inflammatory cells within the tumor microenvironment or baseline necrosis within the primary tumor specimen that influenced the proportion of tumor cells. This evidence concerns the gene VEGFA and neoplasm.